Hyperpigmentation disorders, notably melasma, post- inflammatory hyperpigmentation (PIH) and solar lentigines, are characterised by dysregulated melanocyte activity, resulting in excessive melanin production and deposition
Medicare already covers certain weight loss drugs if they are also approved to treat certain medical conditions
To put that percentage into perspective against currently approved medications: Semaglutide (Wegovy): Produced approximately 14.9% average body weight reduction in its landmark STEP 1 trial over 68 weeks
Biomed Pharmacother 162:114718
12-36, Birtonas Lithuania, LT-59209 email: [email protected] Attachment
Eliud Sifonte, a diabetes and metabolism endocrinologist affiliated with NYU Langone Health, told Flow Space